Basophil Activation Test to Diagnose Food Allergy (BAT2)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Alexandra Santos, MD PhD
- Phone Number: +442071886424
- Email: alexandra.santos@kcl.ac.uk
Study Contact Backup
- Name: Georgia Hill
- Phone Number: 51537 +442071887188
- Email: georgia.hill@gstt.nhs.uk
Study Locations
-
-
-
London, United Kingdom, SE17EH
- Recruiting
- Pediatric Allergy Clinical Research Facility, Evelina Children's Hospital
-
Contact:
- Monica Basting
- Email: monica.basting@kcl.ac.uk
-
Principal Investigator:
- Alexandra Santos, MD PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children ≥6 months and <16 years old;
Suspected IgE-mediated food allergy defined by:
- History of an immediate-type allergic reaction to a specific food or
- No history of consumption of the specific food or
- IgE sensitisation documented by skin prick test (≥1 mm) or serum specific IgE (≥0.10 KU/L);
- Avoidance of the specific food for at least 2 days prior to blood collection for BAT and specific IgE and prior to the challenge;
- Informed consent obtained from parent or guardian and assent obtained from the child.
Exclusion Criteria:
- Clinically significant chronic illness other than atopic diseases;
- Previous history of severe life-threatening reaction to the suspected food with documented decrease in oxygen saturation (<90%), hypotension (≥20% reduction in systolic blood pressure) and/or admission to intensive care;
- Unwillingness to comply with study procedures, namely to undergo a diagnostic food challenge;
Contra-indication for diagnostic food challenge, namely:
- Uncontrolled atopic diseases (e.g. eczema, asthma, rhinitis);
- Chronic medical conditions that pose significant risk in the event of anaphylaxis or treatment of anaphylaxis (e.g. cardiac disease, severe lung disease, pregnancy, mastocytosis);
- Inability to discontinue medications that might interfere with assessment or safety (e.g. antihistamines, β-agonists, β-blockers, NSAIDs, ACE inhibitor, antacids);
- Recent (within 7-14 days) treatment with systemic steroids or prolonged high-dose systemic steroids or immunosuppressants;
- Undergoing treatment with omalizumab, food allergen immunotherapy or other systemic immunomodulatory treatment;
- Inability to stop anti-histamines prior to SPT.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Food allergic
Patients with a positive oral challenge to the food being studied.
|
Patients with suspected food allergy will undergo clinical and dietary assessments and oral food challenge.
Different allergy tests will be performed, including skin prick test, specific IgE test and basophil activation test, and its diagnostic utility will be determined against the clinical gold-standard.
Other Names:
|
|
Non food allergic
Patients with a negative oral challenge to the food being studied.
|
Patients with suspected food allergy will undergo clinical and dietary assessments and oral food challenge.
Different allergy tests will be performed, including skin prick test, specific IgE test and basophil activation test, and its diagnostic utility will be determined against the clinical gold-standard.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic accuracy of the basophil activation test (for each individual food allergy)
Time Frame: 3 years
|
Accuracy of %CD63+ basophils
|
3 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic accuracy of SPT, specific IgE to extracts and to single allergens
Time Frame: 3 years
|
Accuracy of weal diameter or level of IgE
|
3 years
|
|
Association between BAT and severity of symptoms during challenges
Time Frame: 3 years
|
Correlation between %CD63+ basophils and severity grade
|
3 years
|
|
Association between BAT and threshold of reactivity during challenges
Time Frame: 3 years
|
Correlation between CD-sens and cumulative threshold dose
|
3 years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Alexandra Santos, MD PhD, King's College London
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRAS 197886
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Egg Allergy
-
NCT07040111Not yet recruitingEgg Allergy | Food Allergy | Hen Egg Allergy
-
NCT04056299Terminated
-
NCT06998225CompletedHen Egg Allergy | Cow Milk Protein Allergy
-
NCT02083471UnknownEgg Allergy | Cow's Milk Allergy
-
NCT03361072Completed
-
NCT01366846CompletedEgg Allergy | Hypersensitivity | Eczema | Food Allergy
-
NCT01950533CompletedEgg Allergy | Peanut Allergy | Milk Allergy
-
NCT07192510Completed
Clinical Trials on Oral food challenge
-
NCT04651829CompletedReflux, Gastroesophageal | Atopic Dermatitis | Tolerance | Proctocolitis | Food Allergy in Infants
-
NCT06683521RecruitingFood Protein-Induced Enterocolitis Syndrome
-
NCT01950533CompletedEgg Allergy | Peanut Allergy | Milk Allergy
-
NCT07040111Not yet recruitingEgg Allergy | Food Allergy | Hen Egg Allergy
-
NCT06947252Enrolling by invitationAtopic Dermatitis | Food Allergies
-
NCT07592182Not yet recruiting
-
NCT06765213WithdrawnBreast Feeding, Exclusive | Food Allergy in Infants | Food Allergen Sensitisation | Breastmilk Collection
-
NCT06038019RecruitingFood Allergy | Tree Nut Allergy
-
NCT03680066TerminatedPeanut Allergy | Food Allergy | Tree Nut Allergy